Palomar (PLMR) to Release Quarterly Earnings on Monday

Palomar (NASDAQ:PLMRGet Free Report) is expected to be releasing its Q2 2026 results after the market closes on Monday, August 3rd. Analysts expect the company to announce earnings of $2.19 per share and revenue of $621.5250 million for the quarter. Individuals may review the information on the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Tuesday, August 4, 2026 at 12:00 PM ET.

Palomar (NASDAQ:PLMRGet Free Report) last released its earnings results on Wednesday, May 6th. The company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.17 by $0.14. Palomar had a return on equity of 22.62% and a net margin of 20.11%.The firm had revenue of $278.94 million during the quarter, compared to analyst estimates of $557.79 million. During the same period in the prior year, the firm posted $1.87 earnings per share. The business’s quarterly revenue was up 59.7% compared to the same quarter last year. On average, analysts expect Palomar to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

Palomar Stock Performance

NASDAQ PLMR opened at $137.56 on Monday. The business’s 50-day moving average price is $121.82 and its 200 day moving average price is $123.14. The company has a current ratio of 0.49, a quick ratio of 0.49 and a debt-to-equity ratio of 0.31. Palomar has a twelve month low of $100.81 and a twelve month high of $147.62. The company has a market capitalization of $3.65 billion, a PE ratio of 19.16 and a beta of 0.41.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the stock. Evercore set a $152.00 price objective on shares of Palomar in a research note on Friday, July 10th. Piper Sandler boosted their target price on shares of Palomar from $132.00 to $165.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. Keefe, Bruyette & Woods upped their price target on shares of Palomar from $162.00 to $166.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 8th. Zacks Research lowered shares of Palomar from a “strong-buy” rating to a “hold” rating in a report on Friday, May 15th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Palomar from $150.00 to $167.00 and gave the company an “overweight” rating in a research note on Monday, July 20th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Palomar presently has an average rating of “Moderate Buy” and a consensus target price of $162.50.

Check Out Our Latest Research Report on PLMR

Insider Transactions at Palomar

In other news, insider Timothy Carter sold 480 shares of the business’s stock in a transaction dated Sunday, June 28th. The stock was sold at an average price of $124.29, for a total transaction of $59,659.20. Following the completion of the sale, the insider owned 1,670 shares in the company, valued at approximately $207,564.30. The trade was a 22.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, President Jon Christianson sold 6,863 shares of the stock in a transaction that occurred on Thursday, July 2nd. The stock was sold at an average price of $139.50, for a total transaction of $957,388.50. Following the sale, the president directly owned 66,478 shares of the company’s stock, valued at approximately $9,273,681. This trade represents a 9.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 14,343 shares of company stock worth $1,812,773. 3.70% of the stock is currently owned by company insiders.

Institutional Trading of Palomar

Large investors have recently added to or reduced their stakes in the stock. Summit Global Investments lifted its stake in shares of Palomar by 1.7% during the fourth quarter. Summit Global Investments now owns 4,646 shares of the company’s stock worth $626,000 after purchasing an additional 79 shares in the last quarter. Quadrant Capital Group LLC lifted its position in Palomar by 2.0% during the 4th quarter. Quadrant Capital Group LLC now owns 4,464 shares of the company’s stock worth $602,000 after acquiring an additional 88 shares in the last quarter. California State Teachers Retirement System boosted its holdings in Palomar by 0.4% in the 2nd quarter. California State Teachers Retirement System now owns 24,207 shares of the company’s stock worth $3,734,000 after acquiring an additional 97 shares during the period. Smartleaf Asset Management LLC grew its position in Palomar by 25.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 672 shares of the company’s stock valued at $91,000 after acquiring an additional 137 shares in the last quarter. Finally, NewEdge Advisors LLC raised its stake in shares of Palomar by 49.2% during the second quarter. NewEdge Advisors LLC now owns 713 shares of the company’s stock valued at $110,000 after purchasing an additional 235 shares during the period. 90.25% of the stock is currently owned by institutional investors and hedge funds.

Palomar Company Profile

(Get Free Report)

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

Read More

Earnings History for Palomar (NASDAQ:PLMR)

Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.